The result revealed that high level of GLUT3 was closely associated with inferior overall survival of patients with distinct pathologic stages (Fig. 1j–n), while GLUT1 was not associated with prognosis of CRC (Supplementary Fig. S3a–c). The gene discussed is SLC2A3; the disease is colorectal carcinoma.